Temozolomide
NDC 70301-2009, TEMOZOLOMIDE, capsule, from OPKO Pharmaceuticals, LLC.
- Product NDC
- 70301-2009
- Status
- Listed
- Labeler
- OPKO Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203898
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70301-2009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE180 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70301-2009-1 | 70301200901 | 5 PACKET in 1 CARTON (70301-2009-1) / 1 CAPSULE in 1 PACKET |
| 70301-2009-2 | 70301200902 | 14 PACKET in 1 CARTON (70301-2009-2) / 1 CAPSULE in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f743f7e0-74cf-47e5-bf21-f2b75d2596dc
Use it
Look up 70301-2009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70301-2009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70301-2009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.